These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 20689331

  • 1. Erythropoietin protects podocytes from damage by advanced glycation end-products.
    Ruester C, Franke S, Bondeva T, Wolf G.
    Nephron Exp Nephrol; 2011; 117(1):e21-30. PubMed ID: 20689331
    [Abstract] [Full Text] [Related]

  • 2. Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in the db/db mouse.
    Loeffler I, Rüster C, Franke S, Liebisch M, Wolf G.
    Am J Physiol Renal Physiol; 2013 Sep 15; 305(6):F911-8. PubMed ID: 23825071
    [Abstract] [Full Text] [Related]

  • 3. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes.
    Rüster C, Bondeva T, Franke S, Förster M, Wolf G.
    Nephrol Dial Transplant; 2008 Jul 15; 23(7):2179-91. PubMed ID: 18344241
    [Abstract] [Full Text] [Related]

  • 4. Advanced glycation end products suppress neuropilin-1 expression in podocytes by a reduction in Sp1-dependent transcriptional activity.
    Bondeva T, Wolf G.
    Am J Nephrol; 2009 Jul 15; 30(4):336-45. PubMed ID: 19590177
    [Abstract] [Full Text] [Related]

  • 5. Advanced glycation end products inhibit adhesion ability of differentiated podocytes in a neuropilin-1-dependent manner.
    Bondeva T, Wojciech S, Wolf G.
    Am J Physiol Renal Physiol; 2011 Oct 15; 301(4):F852-70. PubMed ID: 21734098
    [Abstract] [Full Text] [Related]

  • 6. Advanced glycation end-products suppress neuropilin-1 expression in podocytes.
    Bondeva T, Rüster C, Franke S, Hammerschmid E, Klagsbrun M, Cohen CD, Wolf G.
    Kidney Int; 2009 Mar 15; 75(6):605-16. PubMed ID: 19037249
    [Abstract] [Full Text] [Related]

  • 7. Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression.
    Liebisch M, Bondeva T, Franke S, Daniel C, Amann K, Wolf G.
    Kidney Int; 2014 Jul 15; 86(1):103-17. PubMed ID: 24476693
    [Abstract] [Full Text] [Related]

  • 8. Parathyroid hormone-related protein induces hypertrophy in podocytes via TGF-beta(1) and p27(Kip1): implications for diabetic nephropathy.
    Romero M, Ortega A, Izquierdo A, López-Luna P, Bosch RJ.
    Nephrol Dial Transplant; 2010 Aug 15; 25(8):2447-57. PubMed ID: 20200004
    [Abstract] [Full Text] [Related]

  • 9. Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products.
    McRobert EA, Bach LA.
    Nephrology (Carlton); 2016 Jan 15; 21(1):13-20. PubMed ID: 26032400
    [Abstract] [Full Text] [Related]

  • 10. Erythropoietin prevents diabetes-induced podocyte damage.
    Schiffer M, Park JK, Tossidou I, Bartels J, Shushakova N, Menne J, Fliser D.
    Kidney Blood Press Res; 2008 Jan 15; 31(6):411-5. PubMed ID: 19096223
    [Abstract] [Full Text] [Related]

  • 11. UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation.
    Lohmann F, Sachs M, Meyer TN, Sievert H, Lindenmeyer MT, Wiech T, Cohen CD, Balabanov S, Stahl RA, Meyer-Schwesinger C.
    Biochim Biophys Acta; 2014 Jul 15; 1842(7):945-58. PubMed ID: 24583340
    [Abstract] [Full Text] [Related]

  • 12. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K.
    Kidney Int; 2005 Oct 15; 68(4):1583-9. PubMed ID: 16164635
    [Abstract] [Full Text] [Related]

  • 13. Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor.
    Chuang PY, Yu Q, Fang W, Uribarri J, He JC.
    Kidney Int; 2007 Oct 15; 72(8):965-76. PubMed ID: 17667983
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
    Xu ZG, Yoo TH, Ryu DR, Cheon Park H, Ha SK, Han DS, Adler SG, Natarajan R, Kang SW.
    Kidney Int; 2005 Mar 15; 67(3):944-52. PubMed ID: 15698433
    [Abstract] [Full Text] [Related]

  • 15. Growth arrest specific 2-like protein 1 expression is upregulated in podocytes through advanced glycation end-products.
    Liebisch M, Bondeva T, Franke S, Hause S, Wolf G.
    Nephrol Dial Transplant; 2017 Apr 01; 32(4):641-653. PubMed ID: 27638909
    [Abstract] [Full Text] [Related]

  • 16. Vitamin D3 Partly Antagonizes Advanced-Glycation Endproducts-Induced NFκB Activation in Mouse Podocytes.
    Rüster C, Franke S, Reuter S, Mrowka R, Bondeva T, Wolf G.
    Nephron; 2016 Apr 01; 134(2):105-116. PubMed ID: 27505422
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors.
    Rüster C, Bondeva T, Franke S, Tanaka N, Yamamoto H, Wolf G.
    Am J Nephrol; 2009 Apr 01; 29(6):538-50. PubMed ID: 19129693
    [Abstract] [Full Text] [Related]

  • 18. The protective effects of erythropoietin on rat glomerular podocytes in culture are modulated by extracellular matrix proteins.
    Krtil J, Pláteník J, Čuřík N, Brima W, Tesař V, Zima T.
    Kidney Blood Press Res; 2013 Apr 01; 38(1):142-55. PubMed ID: 24685986
    [Abstract] [Full Text] [Related]

  • 19. Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms.
    Baba M, Wada J, Eguchi J, Hashimoto I, Okada T, Yasuhara A, Shikata K, Kanwar YS, Makino H.
    J Am Soc Nephrol; 2005 Nov 01; 16(11):3222-34. PubMed ID: 16177004
    [Abstract] [Full Text] [Related]

  • 20. Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo.
    Logar CM, Brinkkoetter PT, Krofft RD, Pippin JW, Shankland SJ.
    Kidney Int; 2007 Aug 01; 72(4):489-98. PubMed ID: 17554257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.